Idera Pharmaceuticals (IDRA) Stock: Headed Up On Update
Idera Pharmaceuticals Inc (NASDAQ: IDRA) is having an incredibly strong start to the trading session this morning, and for good reason. The company updated investors with regard to the company’s strategy this morning, following the news surrounding the termination of the proposed merger with BioCryst Pharmaceuticals. Today, we’ll talk about: The update; what we’re seeing … Read more